Skip to McMaster Navigation Skip to Site Navigation Skip to main content
McMaster logo

CAAIF: Allergic Airways Disease Innovation Grant

Research Admin Offices:

  • HRS

Funding Type:


Opportunity Type:

  • Grant


There are three awards available for a maximum value of $85,000 each for a duration of one year.



Internal Deadline:

January 2, 2023

Sponsor Deadline:

January 16, 2023


The objective of the Allergic Airways Disease Innovation Grant is to fund innovative research of a “high-risk, high-reward” nature that will have impact on the prevention or treatment of allergic airways disease.

These awards are sponsored by CIHR-Institute of Circulatory and Respiratory Health, AstraZeneca Canada and CAAIF.


Additional Details.


If applying from the Faculty of Health Sciences, unless otherwise indicated, you no longer need to send documents to HRS Intake. Your first point of contact is your assigned Senior Grants Advisor.